Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CABAZITAXEL vs CABOZANTINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CABAZITAXEL vs CABOZANTINIB: Safety Overview

Metric CABAZITAXEL CABOZANTINIB
Total FAERS Reports 2,553 3,831
Deaths Reported 467 767
Death Rate 18.3% 20.0%
Hospitalizations 950 2,771
Average Patient Age 68.7 yrs 62.2 yrs
% Female Patients 2.0% 27.5%
FDA Approval Date Dec 29, 2021 N/A
Manufacturer Sanofi-Aventis U.S. LLC N/A
Marketing Status Prescription None